IRIS PubliCatt

Palermo, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.369
NA - Nord America 1.444
AS - Asia 319
AF - Africa 18
SA - Sud America 14
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 2
Totale 9.173
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.896
US - Stati Uniti d'America 1.404
DE - Germania 548
SE - Svezia 301
CN - Cina 157
FR - Francia 136
UA - Ucraina 122
IE - Irlanda 78
GB - Regno Unito 76
SG - Singapore 53
IN - India 47
RU - Federazione Russa 35
FI - Finlandia 33
CA - Canada 30
CH - Svizzera 27
BE - Belgio 24
NL - Olanda 18
ES - Italia 16
JP - Giappone 15
PL - Polonia 14
TR - Turchia 13
HK - Hong Kong 8
GR - Grecia 7
RO - Romania 7
CZ - Repubblica Ceca 6
MA - Marocco 6
AT - Austria 5
BR - Brasile 5
EU - Europa 5
IR - Iran 5
PA - Panama 5
CI - Costa d'Avorio 4
MX - Messico 4
TH - Thailandia 4
TW - Taiwan 4
AR - Argentina 3
ID - Indonesia 3
MD - Moldavia 3
PT - Portogallo 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
CL - Cile 2
CV - Capo Verde 2
EC - Ecuador 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
IS - Islanda 2
MY - Malesia 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
UG - Uganda 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BZ - Belize 1
CO - Colombia 1
EG - Egitto 1
KR - Corea 1
LK - Sri Lanka 1
ME - Montenegro 1
PE - Perù 1
PK - Pakistan 1
RS - Serbia 1
VN - Vietnam 1
Totale 9.173
Salva come PNG Salva come JPEG
Città #
Milan 644
Rome 420
Chandler 347
Naples 165
Ashburn 130
Turin 117
Florence 92
Bologna 84
Palermo 83
Dublin 76
Jacksonville 74
Ann Arbor 73
San Mateo 69
Genoa 60
Catania 56
Wilmington 54
Bari 49
Nanjing 43
Verona 38
Bremen 32
Dearborn 31
New York 31
Los Angeles 30
Singapore 29
Venice 28
Brescia 27
Padova 26
Perugia 26
Ottawa 25
Nürnberg 24
Parma 24
Redwood City 24
Bergamo 23
Cattolica 23
Marseille 23
Reggio Emilia 23
Lawrence 22
Brussels 21
Pescara 21
Woodbridge 21
Messina 20
Moscow 20
Munich 19
Livorno 18
Salerno 17
Boston 16
Falls Church 16
Nanchang 16
Princeton 16
Cagliari 15
Houston 15
Lancaster 15
Taranto 14
Lucca 13
Rimini 13
Monza 12
Trieste 12
Mountain View 11
Novara 11
Redmond 11
Tianjin 11
Kraków 10
Piacenza 10
Beijing 9
Lecce 9
Udine 9
Angri 8
Benevento 8
Boardman 8
Centro 8
Cesena 8
Chicago 8
Fairfield 8
Gorle 8
Helsinki 8
Hong Kong 8
Kunming 8
La Spezia 8
Leawood 8
Modena 8
Pavia 8
Portici 8
Terni 8
Valenzano 8
Vercelli 8
Vicenza 8
Macerata 7
Meda 7
Norwalk 7
Roseto degli Abruzzi 7
Seattle 7
Syracuse 7
University Park 7
Avellino 6
Berlin 6
Cambridge 6
Castellammare di Stabia 6
Forlì 6
Jiaxing 6
Lamezia Terme 6
Totale 3.817
Salva come PNG Salva come JPEG
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 5.893
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 264
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 244
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 138
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 137
Urological complications following inguinal hernioplasty 119
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 110
Hot topics in urological health economics. A mini review 108
Positive surgical margins in nephron sparing surgery for renal cell carcinoma 108
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 107
Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up 100
Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process 100
Imaging in prostate cancer staging: present role and future perspectives 93
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 92
Is microsurgical technique really necessary in inguinal or sub-inguinal surgical treatment of varicocele? 89
Surgery for male urinary incontinence: where are we now and what is in the pipeline? 89
Male sexual dysfunction in patients with chronic end-stage renal insufficiency and in renal transplant recipients 89
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 86
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 85
Therapeutic strategies in penile cancer: state of the art 85
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 83
The occult urothelial cancer 80
The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients 71
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study. 71
Focal surgery in testis cancer: current state of the art 67
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression 60
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 58
Objectively improving appropriateness of absorbent products provision to patients with urinary incontinence: The DIAPPER study 56
Metanephric adenoma with BRAF V600K mutation and a doubtful radiological imaging: pitfalls in the diagnostic process 55
Improved non-invasive diagnosis of bladder cancer with an electronic nose: A large pilot study 55
Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study 54
Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer? 51
Second-Line Conservative Device-Assisted Intravesical Treatment in Selected Patients With Recurrent High-Risk Non–Muscle-Invasive Bladder Cancer 48
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 47
Implementation of frailty preoperative assessment to predict outcome in patients undergoing urological surgery: a systematic review and meta-analysis 43
[Sport, infertility and erectile dysfunction] 34
Bladder tumor markers: A review of the literature 29
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 28
The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder Cancer 17
Imaging in bladder cancer: Present role and future perspectives 17
How to reduce bacillus Calmette-Guérin discontinuation in patients with severe functional impairment 14
The indispensable role of urinalysis for patients undergoing treatment for nonmuscle invasive bladder cancer 14
Rate of clinically significant prostate cancer on repeat saturation biopsy after a diagnosis of atypical small acinar proliferation 13
The new surgical robotic platform HUGOTM RAS: System description and docking settings for robot-assisted radical prostatectomy 9
Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario 9
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 8
Totale 9.227
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.088
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.088
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020322 0 9 14 10 22 26 36 22 64 25 55 39
2020/2021360 10 28 14 30 56 29 45 13 36 13 58 28
2021/2022464 38 29 5 38 36 35 15 62 26 37 69 74
2022/20232.159 173 150 88 196 85 180 98 181 228 174 351 255
2023/20244.326 258 336 300 332 323 346 369 399 343 431 438 451
2024/2025774 471 303 0 0 0 0 0 0 0 0 0 0
Totale 9.227